Showing results (61-70 of 778) with videos related to
Sort By:
Pageof 78
Biometrics|December 22, 2019
A bivariate joint frailty model with mixture framework for survival analysis of recurrent events with dependent censoring and cure fractionRichard Tawiah, Geoffrey J McLachlan, Shu Kay NgBritish Journal of Clinical Pharmacology|April 7, 2020
Potential for pharmacokinetic interactions between Schisandra sphenanthera and bosutinib, but not imatinib: in vitro metabolism study combined with a physiologically-based pharmacokinetic modelling approachJeffry Adiwidjaja, Alan V Boddy, Andrew J McLachlanInternal Medicine Journal|May 16, 2017
Life-threatening drug interactions: what the physician needs to knowRichard O Day, Leone Snowden, Andrew J McLachlanThe Journal of the Louisiana State Medical Society : Official Organ of the Louisiana State Medical Society|March 25, 1998
Mitral valve prolapse. A common cardiac diagnosis in womenJ McLachlan, P C Reddy, T E RattsBiomedical Chromatography : BMC|September 21, 2010
Caffeine and paraxanthine HPLC assay for CYP1A2 phenotype assessment using saliva and plasmaVidya Perera, Annette S Gross, Andrew J McLachlanInternational Journal of Clinical Pharmacy|March 31, 2011
Community pharmacy compounding-impact on professional statusJennifer Anne Giam, Andrew J McLachlan, Ines KrassPharmaceutical Research|June 13, 2020
Physiologically-Based Pharmacokinetic Predictions of the Effect of Curcumin on Metabolism of Imatinib and Bosutinib: In Vitro and In Vivo DisconnectJeffry Adiwidjaja, Alan V Boddy, Andrew J McLachlanStatistical Methods in Medical Research|July 12, 2019
Mixture cure models with time-varying and multilevel frailties for recurrent event dataRichard Tawiah, Geoffrey J McLachlan, Shu Kay NgCPT: Pharmacometrics & Systems Pharmacology|September 28, 2018
A Strategy to Refine the Phenotyping Approach and Its Implementation to Predict Drug Clearance: A Physiologically Based Pharmacokinetic Simulation StudyJeffry Adiwidjaja, Alan V Boddy, Andrew J McLachlanCurrent Drug Metabolism|May 5, 2012
Measurement of CYP1A2 activity: a focus on caffeine as a probeVidya Perera, Annette S Gross, Andrew J McLachlanPageof 78